NGM707

NGM707 · NGM Biopharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NGM707, covering 2024-10-02 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 2]